TMO News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

TM

Mkt Cap

$240.87B

Volume

2.29M

Next Earnings

October 28th

Chart Financials Earnings News About Dividends Insider Filings

Riyadh Global Medical Biotechnology Summit 2026 Closes as a Major Success with SAR 5.5 Billion in Agreements and announcement, Confirming Saudi Arabia's Commitment to Lead the Future of BiotechnologyThe Riyadh Global Medical Biotechnology Summit 2026 concluded successfully with over 15,000 visitors from 57 countries and more than 40 agreements worth SAR 5.5 billion (USD 1.33 billion), significantly exceeding the 2024 edition's USD 100 million. The summit advanced Saudi Arabia's National Biotechnology Strategy through partnerships in vaccine manufacturing, genomics research, clinical trials, and workforce development with international organizations.GlobeNewswire Inc. · Sep 17, 2026

Buy 3 Needham Mutual Funds for Long-Term GainsThe Federal Reserve raised interest rates as anticipated and reported modestly higher inflation expectations. Despite the rate hike, the Fed raised its GDP growth outlook and characterized the labor market as solid, suggesting economic resilience.Zacks Investment Research · Sep 17, 2026

Bioprocess Automation Market Poised for Robust Growth Through 2033, Driven by Demand for Efficient, Scalable BiomanufacturingThe global bioprocess automation market is projected to grow from USD 8.6 billion in 2025 to USD 22.2 billion by 2033, expanding at a CAGR of 12.8%. Growth is driven by rising demand for biologics, advances in AI and robotics, and pressure to improve manufacturing efficiency and regulatory compliance. Automation technologies enhance throughput, consistency, and cost-effectiveness while reducing errors and production time.GlobeNewswire Inc. · Sep 15, 2026

Environmental DNA Market to Reach USD 3.04 Billion by 2031, Growing at a CAGR of 14.9% — MarketsandMarkets™The global environmental DNA market is projected to grow from USD 1.51 billion in 2026 to USD 3.04 billion by 2031, at a CAGR of 14.9%. Growth is driven by increasing demand for non-invasive environmental monitoring, biodiversity conservation efforts, stricter environmental regulations, and advancements in molecular testing technologies. Services and metabarcoding detection methods are leading segments, with Europe as the significant regional market.GlobeNewswire Inc. · Sep 10, 2026

Epigenetics Market Intelligence Report 2026: Strong Demand from Oncology, Precision Medicine, Pharmaceutical Research, and Liquid-Biopsy DevelopmentThe global epigenetics market is estimated at USD 2.70 billion in 2025 and projected to reach USD 8.30 billion by 2034, expanding at a CAGR of 13.3%. Growth is driven by rising cancer burden, precision medicine adoption, liquid-biopsy development, and advances in sequencing technologies. DNA methylation dominates the technology segment at 48% market share, while kits and reagents lead products at 41%. Oncology represents the largest application at 60%, with pharmaceutical and biotech companies as the primary end-users at 44% market share. North America leads with 43% global revenue, while Asia-Pacific is the fastest-growing region.GlobeNewswire Inc. · Sep 9, 2026

Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in FocusZacks highlights strong stock performance from its various rating systems and portfolios. Oportun Financial gained 31% after a Zacks Rank upgrade, Uranium Royalty advanced 67.6% following an Outperform recommendation, and Amgen returned 25.1% over 12 weeks. The article discusses economic conditions marked by geopolitical tensions, rising energy costs, and resilient but cooling labor markets, while showcasing the historical outperformance of Zacks' investment methodologies.Zacks Investment Research · Sep 8, 2026

Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030A comprehensive 249-page veterinary diagnostics market report covering 15 countries and 32 companies has been released, forecasting market trends through 2030. The report analyzes growth drivers including pet ownership patterns, agricultural modernization, and the One Health movement, while examining competitive positioning of major players like IDEXX, Zoetis, Antech, Roche, and Thermo Fisher across various diagnostic assay types, animal categories, and applications.GlobeNewswire Inc. · Sep 7, 2026

Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market ShareThe global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with 34% market share, while Asia Pacific is the fastest-growing region at 15.5% CAGR. Consumables dominate with 68% market share, and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, and laboratory automation.GlobeNewswire Inc. · Sep 4, 2026

TMO Stock Could Gain Following the Launch of EMPAD G2 DetectorThermo Fisher Scientific unveiled the EMPAD G2 detector, enabling faster 4D STEM materials analysis at 10,000 frames per second with atomic-scale characterization. The detector integrates with Velox software for simplified analysis. The global 4D STEM market is projected to grow from $68 million in 2024 to $110 million by 2031 at a 6.6% CAGR, supporting TMO's growth prospects in analytical instruments.Zacks Investment Research · Sep 1, 2026

Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035The global lateral flow assay market is projected to grow from USD 10.84 billion in 2025 to USD 17.66 billion by 2035, with a 5.0% CAGR. Growth is driven by increased adoption of point-of-care testing, technological innovations including CRISPR-based assays, and the shift toward decentralized diagnostic models. Major players include Abbott, Roche, Siemens Healthineers, and Thermo Fisher Scientific, with infectious disease testing accounting for 72.2% of market share.GlobeNewswire Inc. · Aug 31, 2026

TM

TMOThermo Fisher Scientific, Inc.

TMO

Pay with—

Available Balance0.00

Your PositionYou don't own any TMO yet.

Related Tickers

Earnings

Dividends

Last · Sep 15Quarterly

Amount$0.47

Yield0.29%

Annual$1.88